DDD 2020-06-30 Supporting Materials (ex 99.4)

2y ago
10 Views
2 Downloads
815.51 KB
24 Pages
Last View : 15d ago
Last Download : 2m ago
Upload by : Aiyana Dorn
Transcription

Investor PresentationMarch 2021 2021 3D Systems, Inc. All Rights Reserved.

Safe HarborCertain statements made in this presentation that are not statements of historical or current facts are forward-looking statements within the meaning of the Private SecuritiesLitigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections,developments, future events, performance or products, underlying assumptions, and other statements which are other than statements of historical facts. In some cases, youcan identify forward-looking statements by terms such as “believes,” “beliefs,” ''may,'' ''will,'' ''should,'' expects,'' ''intends,'' ''plans,'' ''anticipates,'' ''estimates,'' ''predicts,'' ''projects,''''potential,'' ''continue,'' and other similar terminology or the negative of these terms. From time to time, we may publish or otherwise make available forward-looking statementsof this nature. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by the cautionary statementsdescribed in this message including those set forth below.Forward-looking statements are based upon management’s beliefs, assumptions and current expectations concerning future events and trends, using information currentlyavailable, and are necessarily subject to uncertainties, many of which are outside our control. In addition, we undertake no obligation to update or revise any forward-lookingstatements made by us or on our behalf, whether as a result of future developments, subsequent events or circumstances, or otherwise, or to reflect the occurrence or likelihoodof unanticipated events, and we disclaim any such obligation.Forward-looking statements are only predictions that relate to future events or our future performance and are subject to known and unknown risks, uncertainties, assumptions,and other factors, many of which are beyond our control, that may cause actual results, outcomes, levels of activity, performance, developments, or achievements to bematerially different from any future results, outcomes, levels of activity, performance, developments, or achievements expressed, anticipated, or implied by these forward-lookingstatements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be reliedupon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results willbe achieved. 3D Systems' actual results could differ materially from those stated or implied in forward-looking statements. Past performance is not necessarily indicative offuture results. We do not undertake any obligation to and do not intend to update any forward-looking statements whether as a result of future developments, subsequentevents or circumstances or otherwise.Further, we encourage you to review “Risk Factors” in Part 1 of our Annual Report on Form 10-K and Part II of our quarterly reports on Form 10-Q filed with the SEC as well asother information about us in our filings with the SEC. These are available at www.SEC.gov.2

Key MessagesNew management team executinga transformation journeyA leader in a large growth market3Full Solution capabilities with focuson application driven growth

New Leader. New Future.Dr. Jeffrey Graves is President and CEO of 3D Systems and joined thecompany on May 26, 2020.Prior to joining 3D Systems, from 2012 to May 2020, he served as CEO,President and Director of MTS Systems Corporation, a global supplier oftest, simulation, and measurement systems. From 2005 until 2012, heserved as President and CEO of C&D Technologies, Inc. He also heldleadership roles with Kemet Corporation as Chief Operating Officer (20012003) and CEO (2003 to 2005). Previously he held a number of leadershipand technical roles with GE, Rockwell Automation and Howmet Corporation.Graves currently serves on the Board of Directors of FARO Technologiesand Hexcel Corporation.He holds a bachelor’s degree in metallurgical engineering from PurdueUniversity. He also holds a master’s degree and PhD in metallurgicalengineering from the University of Wisconsin. He has been recognized withthe distinguished alumni award from both universities. He is also a masterblack belt in six sigma.4

Purpose StatementWe are the leaders in enabling additive manufacturing solutions forapplications in growing markets that demand high reliability products.5

Transformation FrameworkStrategicPurposeWe are the leaders inenabling additivemanufacturing solutionsfor applications in growingmarkets that demand highreliability products.ReorganizeRestructureFocus on Key Applicationswithin Healthcare andIndustrial MarketsExperiencedManagement Team6Divest/InvestResizing other costreduction measuresDivest non-core assetsand Invest for growthAchieved 60M Run-RateCost Savings in 2020Well positioned toleverage the sales growthas it returns and capturethe market growth ofadditive manufacturing

Why AM? Tangible Benefits to AM DesignImproved LeadTimesCapability for MassCustomizationPart / AssemblyConsolidationSupply ChainOptimization andFlexibilityWeightReduction7PrecisionParts

Market Opportunity:AM Growth EstimateSCALE OF AM GROWTHOver the next 5 years, market isexpected to grow on average at 24%CAGR, reaching 35B by 2024INDUSTRY GROWTH DRIVERSHigh focus to introduce new designs &business models that take full advantageof the manufacturing freedomGrowth is expected in system placement,material usage and printing services andreplace end-use production processesTop customers in high growth verticals Healthcare, Automotive, Durable Goods,and Aerospace are squarely focused onAM exploration and adoptionSource: 3D Hubs8

Application FocusHealthcare SolutionsIndustrial SolutionsDental ApplicationsAerospace & DefenseMedical ApplicationsTransportation & MotorsportsMedical DevicesInvestment CastingsSimulationsJewelrySurgical PlanningConsumer Durables & ElectronicsFocus on Key Applications within these Markets9

Full Solution ProviderServices and SoftwareHardware and MaterialsApplication experts & CustomerInnovation CentersFull range of 3D printers to addressAM needs in metals, plastics and waxPrinting process and managementsoftware toolsProfessional and production systemsOn Demand Manufacturing –printing services100 Materials portfolio forprototyping and productionapplicationsFull service and support post-purchaseProduction ExperienceGlobal ReachDeep and diverse experience inproduction parts and applicationsService Experts across 5 continentsProven across an install base that printsup to 500,000 production parts per dayusing 3D Systems solutionsLocal to over 80% of customer baseInnovation Centers in US & EuropeSix Manufacturing locations aroundthe globe10Capabilities tohelp customersevaluate, testand scale additivemanufacturinginto their business

Healthcare Case StudyVA ObjectivesVeterans HealthAdministration (VHA) COVID-19 related manufacturingEstablish quality management systemDevelop patient-matched medical device productsRegulatory compliance3D Systems Solution 3D Systems will assist the VA withestablishing additive manufacturingproduction capabilities for medicaldevices to improve treatment forU.S. Veteran patientsHardware / materialsSoftwareQMS & regulatory consultingManaged service manufacturingExpected Outcomes 11Supply chain independenceImproved patient careRetention of patientsReduced procedure costsInvestment in American jobs

Healthcare Case StudyCustomer ChallengeOrthopedicMachining-plus-coating traditional design and manufacturingprocesses lead to poor surface quality, high componentvariability, long process cycle times, high inventory and wastelevels, and sub-optimal implant performance.Utilized holistic solutions approachto develop and commercialize thestate-of-the-art total joint implantwith engineered surface andoptimized mechanical properties3D Systems Solution Factories – Two ISO13485 certified factories and validatedworkflows for accelerated product commercialization People – Application Engineers, Metals R&D EngineeringTeams that can optimize Design for Manufacturing Hardware – DMP Flex 350 (High purity Titanium printer) Software – 3DXpert and customized softwareOutcomeAn economically viable orthopedic implant with optimizedsurface characteristics and mechanical properties forsuperior performance.12

Industrial Case StudyInvestment CastingCustomer ChallengeTraditional investment casting production methodologylimits geometric design options and involves long,complex manufacturing cycle times.Utilized holistic solutions withmaterials, hardware and softwareelements tuned by applicationexperts to solve the challenge3D Systems Solution Materials (resins) that provide consistent performance,accuracy and dimensional stability, with clean burnout,highly stable dimensional control and ultra-low ashcontent Software with hollow lattice filled build styles and printprocess parameters that provide sufficient strength forprocessing while being easily and efficiently removedlate in the process Stereolithography printers that set the standard foraround-the-clock, reliable high performanceOutcomeState-of-the-art cast metal parts with highly complexgeometries to enable improved levels of performance atreduced cost13

Investing for GrowthMATERIALSDEVELOPMENTORGANIZATIONAL Solution sellingcapabilityPeople and talentCustomer SuccessTeam created tofocus on aftermarketefforts PolymerHigh-temperature,lightweight materialsfor industrialapplications14PROGRAMS RegenerativeMedicineRoadrunner ‘HighSpeed Fusion’ProductEnhancements

Regenerative MedicineIndustry ChallengesThrough bioprinting, we have anDemonstrate the capability to print complex thin-opportunity to address patient needswalled structured using biocompatible materials forfor organs and soft tissue developmentapplications such as tissue-on-a-chip,using Additive Manufacturingbioresorbable implants, grafts and solid organs3D Systems OpportunityTo create a sustainable business to address patientoutcomes through bioprinting revenue and growthStrategyAccelerate efforts in 2021 by leveraging theprogress on United Therapeutics-funded LungHuman vasculature model created usingPrint to Perfusion process(Image courtesy of United Therapeutics)Program and our foundation in Healthcare topursue a range of applications15 2021 3D Systems, Inc. All Rights Reserved.

“Roadrunner”High Speed FusionIndustry ChallengesAddress demanding aerospace and advancedSpecific Applicationsautomotive applications with size, speed andprecision that exceeds current market offerings.– Direct Printing: aerospace interiorsand ducting, drone components,automotive under dash and underhood, and other general industrialapplications3D Systems OpportunityTo provide the most advanced platform of any high– Tooling & Fixtures: manufacturingaids, automation and robotics tooling,lift assist tooling, as well as moldsand sacrificial toolsthroughput industrial fused-filament offering in themarket todayStrategy– Prototyping Parts: automotive,aerospace, medical, heavyequipment, and general industrysupport.16Work with Jabil to commercialize this new 3Dprinting platform, leveraging 3D Systems’ materialscapabilities, and accelerate adoption in the market 2021 3D Systems, Inc. All Rights Reserved.

Quarter ended 12/31/20 in millionsQ4 2020 Revenue by Market(Unaudited)42.4%14.2%48.0%(21.6)%17

Operating Expense TrendNon-GAAP operating expenses decreased 15.8% in Q4 2020 compared to Q42019 as we saw benefits of restructuring effortsSee appendix for a reconciliation of Non-GAAP operating expenses.18

Adjusted EBITDADefined as non-GAAP Operating Income plus DepreciationQ4 2020 improvement as a result of business growth and restructuring effortsSee appendix for a reconciliation of Non-GAAP Operating Profit and Adjusted EBITDA.19

SummaryOur Transformation Journey Continues: Reorganization and Restructuring complete Exploring additional divestitures of non-core assets Investing for growth in core business of additive manufacturing Focus on operational execution20

Thank YouFind out more at:www.3dsystems.com2211 2019 3D Systems, Inc. All Rights Reserved.

Appendix 2021 3D Systems, Inc. All Rights Reserved.

Non-GAAP Reconciliation - Operating Income (Loss) (Unaudited)Fourth Quarter and Full Year Non-GAAP Operating Loss(in millions, except per share amounts)GAAP Operating income (loss)Adjustments:Amortization, stock-based compensation & other (1)Legal, acquisition and divestiture related (2)Cost optimization plan, including severance costs (3)Product end of life adjustment (4)Goodwill impairment (5)Non-GAAP Operating income (loss)Depreciation (6)Adjusted EBITDAQuarter Ended December 31,202020190.7 (4.7) 4.13.87.6——16.16.822.9 8.21.50.7——5.77.312.9 Year Ended December 31,20202019(119.0) (57.1)33.44.522.310.948.30.328.428.7 43.96.77.7——1.230.031.2(1)For the quarter ended December 31, 2020, the adjustment included 0.1 in COGS and 4.0 in SG&A. For the quarter ended December 31, 2019, the adjustment included 0.1 in COGS and 8.1 in SG&A.For the twelve months ended December 31, 2020, the adjustment included 0.4 in COGS and 33.0 in SG&A. For the twelve months ended December 31, 2019, the adjustment included 0.4 in COGS and 43.4 in SG&A.(2)For the quarter ended December 31, 2020, the adjustment included 0.1 in COGS and 3.7 in SG&A. For the quarter ended December 31, 2019, the adjustment included 0.1 in COGS and 1.4 in SG&A.For the twelve months ended December 31, 2020, the adjustment included 0.4 in COGS and 4.1 in SG&A. For the twelve months ended December 31, 2019, the adjustment included (2.9) in Revenues, 4.1 in COGS and 5.5 in SG&A.(3)For the quarter ended December 31, 2020, the adjustment included 1.5 in COGS and 6.1 in SG&A. For the quarter ended December 31, 2019, the adjustment included 0.1 in COGS and 0.6 in SG&A.For the twelve months ended December 31, 2020, the adjustment included 2.2 in COGS, 19.9 in SG&A and 0.1 in R&D. For the twelve months ended December 31, 2019, the adjustment included 1.8 inCOGS, 5.6 in SG&A and 0.3 in R&D.(4)For the twelve months ended December 31, 2020, the adjustment included 10.9 in COGS.(5)For the twelve months ended December 31, 2020, the adjustment included 48.3 in Impairment of goodwill.(6)For the quarter ended December 31, 2020, the adjustment included 3.0 in COGS, 2.5 in SG&A and 1.3 in R&D. For the quarter ended December 31, 2019, the adjustment included 3.1 in COGS, 2.5 inSG&A and 1.8 in R&D. For the twelve months ended December 31, 2020, the adjustment included 12.2 in COGS, 9.8 in SG&A and 6.4 in R&D. For the twelve months ended December 31, 2019, theadjustment included 12.6 in COGS, 10.4 in SG&A and 7.0 in R&D.* Tables may not foot due to rounding; amounts calculated based on dollars in thousands.23

Non-GAAP Reconciliation - Operating Expense (Unaudited)Quarterly 2019 and 2020 Non-GAAP Operating Expenses(in millions)GAAP SG&A ExpensesMar 31 65.12019201920202020Quarter EndedFullQuarter EndedFullJun 30 Sep 3071.7 58.3Dec 31 YearMar 31Jun 30Sep 30Dec 31Year59.3 254.4 56.1 52.0 59.1 52.7 219.9GAAP R&D AP Goodwill ImpairmentGAAP Operating 4—69.048.3126.2—71.748.3342.3Cost optimization planNon-GAAP R&D —17.0—18.9—19.00.174.0Adjustments to SG&A Expenses:Amortization, stock-basedcompensation & .2)1.45.50.20.10.13.74.1Adjustments to R&D Expenses:Legal and 9Total Adjustments to SG&A ExpensesCost optimization AP SG&A ———————48.3—48.363.0 57.1 Goodwill impairment adjustmentNon-GAAP Operating Expenses 72.9 71.7 69.3 68.9 282.8 * Tables may not foot due to rounding; amounts calculated based on dollars in thousands.2458.8 58.0 236.9

Mar 25, 2021 · materials, hardware and software elements tuned by application experts to solve the challenge. 3D Systems Solution Materials (resins) that provide consistent performance, accuracy and dimensional stability, with clean burnout, highly stable dimensional control and ultra-low ash content Software with hollow lattice filled build styles .

Related Documents:

A temporary DDD help desk has been established for you to submit questions related to DDD's response to the COVID-19 situation. Fee-For-Service Help Desk: DDD.FeeForService@dhs.nj.gov For any questions related to the fee-for-service system, requests for Tier Assignment Letters and to report PPL-related issues.

0403 Oslo Norway Visiting address: Marcus Thranes gate 6, 0473 Oslo, Norway Tel: 47 21 07 81 60 Fax: 47 21 07 81 46 E-mail: whocc@fhi.no ATC classifi cation. Guidelines for ATC classification and DDD assignment 2011. ISSN 1726-4898 ISBN 978-82-8082-438-7

EU Tracker Questions (GB) Total Well Total Badly DK NET Start of Fieldwork End of Fieldwork 2020 15/12/2020 16/12/2020 40 51 9-11 08/12/2020 09/12/2020 41 47 12-6 02/12/2020 03/12/2020 27 57 15-30 26/11/2020 27/11/2020 28 59 13-31 17/11/2020 18/11/2020 28 60 12-32 11/11/2020 12/11/2020 28 59 12-31 4/11/2020 05/11/2020 30 56 13-26 28/10/2020 29/10/2020 29 60 11-31

July 2, 2002 . II. INDICATIONS FOR USE The InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device is indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one level from L 4-S 1. DDD is defined as discogenic back pain with

The purpose of these operational guidelines is to provide guidance on how to implement changes that will be in effect for the duration of the declared COVID-19 emergency. These guidelines will be updated as necessary and will be posted on-line at https://health.hawaii.gov/ddd/ representing the content and dates of changes to the Appendix

Provider Operational Guideline Manual Serve · Empower · Support Promoting the health and well-being of Alabamians with mental illness, developmental disabilities and substance use disorders. DDD implements the Mission and Vision of the Alabama Department of Mental Health by assuring that people with Developmental Disabilities are

QQQQSDDD llll uuuua bbb Z&&& eeeesyyy uuuukkk eeee ,,, ooooa iiiirrrrkkk nnnnwjjj HHHH kkkkkkkk ’’’’kkkk dddd z @@@ ddd kkkkss ssMMM QQQQSDDD llll uuuua bbbbZ&&& eeeeyysy uuu kkkkeeee ,,,,oooa iiiirrrr kkkk nnnnwjjj HHHHkkkk kkkk’’’ kkkk dddd zz zz @@@@ddd kkkksMMM QQQQSDDD lll uuuua bbb Z&&& eeeesyyy

KKKK 12 11 13 T TT T ( 2 x G GG G ) T TT T KKKK ( 2 x G GG G ) KKKK KKKK KKKK KKKK KKKK KKKK KKKK KKKK 13 2 x EEEE 2 x EEE Ø 8 x 40mm E EE E x 20 UUUU UUUU Ø 4,5 x 50mm KKK x 10. 9 7 DDDD DDDD DDDD QQQQ QQQQ QQQ QQQ 3 4 QQQ QQQQ QQQ QQQ QQQQ 2 x DDD 2 x DDD 2 x DDDD 2 x DDDD QQQQ 5/12 4 5 x2 Ce document